ロード中...
Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans
CONTEXT: In 2005, HEDIS introduced a quality measure to assess the receipt of disease modifying anti-rheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA). OBJECTIVE: To identify sociodemographic, community, and health-plan factors associated with DMARD receipt among Medicare manage...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3172813/ https://ncbi.nlm.nih.gov/pubmed/21285425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.67 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|